INSIGHTS ON LIQUID DOSE MANUFACTURING

• Solutions In Pre-Filled Syringes For Biologics And Ophthalmic Applications

  Discover how pharma companies can select tailored pre-filled syringes for biologics and biosimilars by aligning drug delivery needs with specialized containers and analytical services.

• Efficient, Single-Source PFS Supply

  When component lead times don’t align, inventory piles up, cash gets tied up, and forecasts can quickly turn into waste or shortages. What if a single integrated PFS system could simplify it all?

• CDMO Partnerships: Why Speed And Flexibility Matter Now More Than Ever

  As demand for GLP-1s and biologics accelerates and timelines compress, it's become more crucial that pharmaceutical companies stay competitive and bring therapies to market faster by partnering with a CDMO.

• The Journey Of A CDMO Choosing Pre-Sterilized Drug Containers

  Explore innovation in pharmaceutical manufacturing with advanced drug containment, delivery systems, and automation, ensuring quality, safety, and efficiency in injectable therapies for global healthcare.

   

• Vial Breakage During Lyophilization: Root Causes And Mitigation

  10/16/2024

  Learn how controlling freezing rates, using specialized vials, and employing optimized stoppering techniques can reduce the risk of vial breakage during lyophilization and ensure high product quality.

• Streamline Your Path To Clinical Fill

  5/21/2026

  Drug-independent PFS testing is a required early step — but it can be time-consuming and resource-intensive. What if you could eliminate the effort without losing the data you need?

• Water For Injection: Strategic Utility And The Case For Outsourcing

  3/9/2026

  Water for Injection is a critical, highly regulated component of sterile drug manufacturing. Outsourcing its production offers faster timelines, reduced risk, and improved operational and cost efficiency.

• Biofluorescent Particle Counters Are Gaining Momentum

  4/28/2025

  The 2025 BioPhorum report highlights challenges and trends in drug filling operations and how they are advancing towards biofluorescent particle counters. Discover an approach that aligns with industry needs.

• 0.45 m/s ±20% At Working Position In Closed Sterility Testing Isolators: Requirement Or Convention?

  2/19/2026

  Balance compliance and efficiency in sterility testing. Explore how a risk-based approach to airflow and isolator technology aligns with Annex 1 while optimizing contamination control.